Molecular Imaging of Peritoneal Carcinomatosis in Ovarian Carcinoma.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32551907.
- Also identified by DOI 10.2214/AJR.19.22621.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<b>OBJECTIVE.</b> This article discusses the emerging roles of <sup>18</sup>F-FDG PET/CT and DWI in the assessment of peritoneal carcinomatosis in ovarian carcinoma from diagnostic accuracy to disease prognostication with gross pathologic correlation. <b>CONCLUSION.</b> PET/CT and DWI have incremental clinical values over conventional modalities with high predictive values of incomplete cytoreduction in ovarian carcinoma. The respective quantitative metrics offer evaluation of tumor burden with prognostic value in ovarian carcinoma.
Medical subject headings
- Diffusion Magnetic Resonance Imaging
- Fluorodeoxyglucose F18
- Ovarian Neoplasms
- Peritoneal Neoplasms
- Positron Emission Tomography Computed Tomography
- Radiopharmaceuticals